×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
c-MYC anticorps (pThr358)
MYC
Reactivité: Humain, Souris
WB, IF, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
Détail du produit anti-c-MYC anticorps
(cache)
Antigène
Voir toutes c-MYC (MYC) Anticorps
c-MYC (MYC)
(Myc Proto-Oncogene protein (MYC))
Épitope
Tous les épitopes à travers c-MYC Anticorps.
pThr358
Reactivité
Toutes les réactivités sur c-MYC Anticorps
Humain, Souris
Hôte
Toutes les hôtes sur c-MYC Anticorps
Lapin
Clonalité
Toutes les clonalités sur c-MYC Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers c-MYC Anticorps
Cet anticorp c-MYC est non-conjugé
Application
Tous les applications à travers c-MYC Anticorps.
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Specificité
Myc (phospho-Thr358) antibody detects endogenous levels of Myc only when phosphorylated at threonine 358.
Purification
Immunoaffinity chromatography
Immunogène
Synthetic phosphopeptide derived from human Myc around the phosphorylation site of threonine 358 (R-R-TP-H-N).
Top Product
Discover our top product MYC Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Suitable for use in Western blot (1: 500approx. 1: 1000) and Immunohistochemistry (1: 50approx. 1: 100). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Stockage
(cache)
Concentration
1.0 mg/mL
Buffer
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl containing 0.02 % Sodium Azide as preservative and 50 % glycerol as stabilizer
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
-20 °C
Stockage commentaire
Store the antibody (in aliquots) at -20 °C.
Détails sur c-MYC
(cache)
Antigène
c-MYC (MYC)
(Myc Proto-Oncogene protein (MYC))
Autre désignation
C-Myc (MYC Produits )
Synonymes
anticorps MRTL, anticorps MYCC, anticorps bHLHe39, anticorps c-Myc, anticorps CMYC, anticorps c-myc, anticorps C-MYC, anticorps LOC100136746, anticorps ARC, anticorps B430311C09Rik, anticorps MYC, anticorps NOP, anticorps Nop30, anticorps RNCMYC, anticorps mMyc, anticorps AU016757, anticorps Myc2, anticorps Niard, anticorps Nird, anticorps cmyc, anticorps zc-myc, anticorps c-myc II, anticorps myc-B, anticorps myc2, anticorps myc1, anticorps CMyc, anticorps zgc:55680, anticorps CG10798, anticorps D-Myc, anticorps DM, anticorps DMYc, anticorps Dm, anticorps Dmel\CG10798, anticorps Dmyc, anticorps EG:BACN5I9.1, anticorps anon-WO03040301.171, anticorps bHLHe57, anticorps c-MYC, anticorps d-myc, anticorps dMYC, anticorps dMyc, anticorps dMyc1, anticorps da, anticorps dm, anticorps dm/dMyc, anticorps dm/myc, anticorps dmyc, anticorps dmyc1, anticorps l(1)G0139, anticorps l(1)G0354, anticorps l(1)G0359, anticorps myc, anticorps MYC proto-oncogene, bHLH transcription factor, anticorps v-myc myelocytomatosis viral oncogene homolog, anticorps nucleolar protein 3 (apoptosis repressor with CARD domain), anticorps myelocytomatosis oncogene, anticorps MYC proto-oncogene, bHLH transcription factor a, anticorps MYC proto-oncogene, bHLH transcription factor L homeolog, anticorps MYC proto-oncogene, bHLH transcription factor S homeolog, anticorps v-myc myelocytomatosis viral oncogene homolog (avian), anticorps MYC proto-oncogene, bHLH transcription factor b, anticorps CG10798 gene product from transcript CG10798-RB, anticorps MYC, anticorps LOC100136746, anticorps Nol3, anticorps Myc, anticorps myca, anticorps myc.L, anticorps myc.S, anticorps mycb
Sujet
Synonyms: BHLHE39, Class E basic helix-loop-helix protein 39, Myc proto-oncogene protein, Transcription factor p64
ID gène
4609
NCBI Accession
NP_002458
UniProt
P01106
Pathways
Signalisation p53 , Cycle Cellulaire , Sensory Perception of Sound , Transition Metal Ion Homeostasis , Mitotic G1-G1/S Phases , Positive Regulation of Endopeptidase Activity , Regulation of Carbohydrate Metabolic Process , Positive Regulation of Response to DNA Damage Stimulus , L'effet Warburg
Vus récemment
(cache)